Gilead Sciences
- J01 - Antibacterianos para uso sistémico
- CAYSTON AVEC SOLVANT powder for nebuliser solution 75 mg
- J02 - Antimicóticos de uso sistémico
- AMBISOME LIPOSOMAL powder for suspension for injection 50 mg
- AMBISOME powder for suspension for injection 50 mg
- J05 - Antivirales de uso sistémico
- BIKTARVY film-coated tablet 30 mg+120 mg+15 mg
- BIKTARVY film-coated tablet 50 mg+200 mg+25 mg
- EMTRIVA capsule, hard 200 mg
- EMTRIVA oral solution 10 mg/ml
- EPCLUSA EN SACHET-DOSE granules 150 mg+37.5 mg
- EPCLUSA EN SACHET-DOSE granules 200 mg+50 mg
- EPCLUSA film-coated tablet 200 mg+50 mg
- EPCLUSA film-coated tablet 400 mg+100 mg
- EVIPLERA film-coated tablet 200 mg+25 mg+245 mg
- GENVOYA film-coated tablet 150 mg+150 mg+200 mg+10 mg
- HARVONI film-coated tablet 90 mg+400 mg
- HEPCLUDEX powder for solution for injection 2 mg
- ODEFSEY film-coated tablet 200 mg+25 mg+25 mg
- SOVALDI film-coated tablet 400 mg
- STRIBILD film-coated tablet 200 mg+245 mg+150 mg+150 mg
- SUNLENCA film-coated tablet 300 mg
- SUNLENCA solution for injection 464 mg
- TRUVADA film-coated tablet 245 mg+200 mg
- VEKLURY powder for solution for infusion 100 mg
- VIREAD film-coated tablet 123 mg
- VIREAD film-coated tablet 163 mg
- VIREAD film-coated tablet 204 mg
- VIREAD film-coated tablet 245 mg
- VIREAD granules 33 mg/g
- VOSEVI film-coated tablet 400 mg+100 mg+100 mg
- L01 - Antineoplásicos
- TECARTUS dispersion 40 to 200 M.cells
- TRODELVY powder for solution for infusion 200 mg
- YESCARTA dispersion 40- 200 M.cells
- ZYDELIG film-coated tablet 100 mg
- ZYDELIG film-coated tablet 150 mg